Status:
TERMINATED
Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Allogeneic Hematopoietic Cell Transplantation
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The central hypothesis is that daily dental xylitol wipes, in addition to current oral care practice, are effective at reducing BSI from oral organisms, and decreasing the incidence of gingivitis, ora...
Detailed Description
Our long-term goal is to develop and disseminate clinically relevant, and easily adoptable strategies to prevent BSI and improve outcomes after SCT. The overall objective of this proposal is to identi...
Eligibility Criteria
Inclusion
- Patients of any age undergoing SCT.
Exclusion
- Prior proton or photon radiation treatment for cancer of the oral cavity, head or neck; cranial boost in patients receiving total body irradiation; known history of allergy to xylitol; inability to use a mouth rinse or dental wipes.
Key Trial Info
Start Date :
September 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04117477
Start Date
September 27 2019
End Date
March 20 2021
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229-3039